UY39463A - Microsuspensión contra parásitos y método para obtenerla - Google Patents

Microsuspensión contra parásitos y método para obtenerla

Info

Publication number
UY39463A
UY39463A UY0001039463A UY39463A UY39463A UY 39463 A UY39463 A UY 39463A UY 0001039463 A UY0001039463 A UY 0001039463A UY 39463 A UY39463 A UY 39463A UY 39463 A UY39463 A UY 39463A
Authority
UY
Uruguay
Prior art keywords
microsuspension
against parasites
parasite
microns
animals
Prior art date
Application number
UY0001039463A
Other languages
English (en)
Inventor
Claudio Mascaro
Original Assignee
Ipanema Ind De Produtos Veterinarios Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipanema Ind De Produtos Veterinarios Ltda filed Critical Ipanema Ind De Produtos Veterinarios Ltda
Publication of UY39463A publication Critical patent/UY39463A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P5/00—Nematocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una microsuspensión contra parásitos en animales y su método de preparación, más particularmente dirigida a la industria veterinaria. La microsuspensión contra parásitos incluye lactona macrocíclica y sulfóxido de albendazol, y presenta un tamaño de partícula promedio de D50 = 250 micras.
UY0001039463A 2020-10-16 2021-10-08 Microsuspensión contra parásitos y método para obtenerla UY39463A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102020021181-1A BR102020021181A2 (pt) 2020-10-16 2020-10-16 Microssuspensão contra parasitas e método para sua obtenção

Publications (1)

Publication Number Publication Date
UY39463A true UY39463A (es) 2022-05-31

Family

ID=81207349

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039463A UY39463A (es) 2020-10-16 2021-10-08 Microsuspensión contra parásitos y método para obtenerla

Country Status (7)

Country Link
US (1) US20240000752A1 (es)
EP (1) EP4230203A1 (es)
AR (1) AR123832A1 (es)
AU (1) AU2021361343A1 (es)
BR (1) BR102020021181A2 (es)
UY (1) UY39463A (es)
WO (1) WO2022077087A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118384108A (zh) * 2024-04-24 2024-07-26 临沂金翠兽药有限公司 一种动物用耐候高生物利用度的驱虫混悬液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915986A (en) 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
GB2025223A (en) 1978-07-17 1980-01-23 Syntex Inc Injectable anthelmintic benzimidazole compositions
EP0705101B1 (en) 1993-05-26 2001-12-19 Commonwealth Scientific And Industrial Research Organisation Antiparasitic compositions
EP0919231A1 (en) 1997-10-15 1999-06-02 Biogenesis, S.A. Injectable parasiticide composition and process for the preparation
NZ534939A (en) 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
JP5342239B2 (ja) * 2005-12-06 2013-11-13 ゾエティス・ダブリュー・エルエルシー ベンジイミダゾール非水性組成物
CA2660647C (en) * 2006-06-14 2015-07-28 Intervet International B.V. A suspension comprising benzimidazole carbamate and a polysorbate
CN101984958B (zh) * 2010-11-01 2012-08-08 新疆医科大学第一附属医院 纳米级阿苯达唑微粉及其制备方法
NZ619290A (en) * 2010-12-08 2015-04-24 Jurox Pty Ltd Anthelmintic formulation
AU2013205280A1 (en) * 2012-04-19 2013-11-07 Alleva Animal Health Limited Macrocyclic Lactone injectable Formulations
BR102013031277B1 (pt) 2013-12-05 2018-10-02 Ouro Fino Participacoes E Empreendimentos S A processo para preparar uma suspensão anti-helmíntica e suspensão anti-helmíntica injetável
CN103800355A (zh) * 2014-02-26 2014-05-21 江苏斯威森生物医药工程研究中心有限公司 一种含伊维菌素、丙硫亚砜和吡喹酮复方长效微球驱虫药
BG2358U1 (bg) * 2016-03-23 2016-12-30 "Ендектовет" Еоод Антихелминтно средство
CN106389456B (zh) * 2016-11-16 2020-06-09 佛山市正典生物技术有限公司 一种兽用阿苯达唑伊维菌素预混剂及其制备方法
RU2732293C1 (ru) * 2019-11-26 2020-09-15 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. К.И. Скрябина и Я.Р. Коваленко" (ФГБНУ ФНЦ ВИЭВ РАН) Супрамолекулярный антигельминтный комплекс для лечения и профилактики животных при основных гельминтозах

Also Published As

Publication number Publication date
AU2021361343A1 (en) 2023-06-08
AR123832A1 (es) 2023-01-18
US20240000752A1 (en) 2024-01-04
AU2021361343A9 (en) 2024-07-25
BR102020021181A2 (pt) 2022-04-26
WO2022077087A1 (pt) 2022-04-21
EP4230203A1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
EP4025934A4 (en) PROCESSING OF LIDAR IMAGES
UY39463A (es) Microsuspensión contra parásitos y método para obtenerla
ECSP17011630A (es) Encapsulación de compuestos hidrofóbicos biológicamente activos
EP4361281A3 (en) Acidophilic fusarium oxysporum strains, methods of their production and methods of their use
GT201600208A (es) Dispersión sólida amorfa que comprende taxano, comprimido que comprende la misma, y método para su preparación
MX2022010831A (es) Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
WO2015184311A3 (en) Method of feeding an animal
BR112017014340A2 (pt) quitina, hidrolisado e método para a produção de um ou mais produtos desejados a partir de insetos por meio de hidrólise enzimática
PH12019500610A1 (en) Controlled release tablet based on polyvinyl alcohol and its manufacturing
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
CL2017000674A1 (es) Método para alimentación de peces, método para la esmoltificación y la prevención de la desmoltificación de salmónidos, y para la profilaxis y tratamiento del síndrome hemorrágico del smolt (shs) en salmónidos
BR112019007476A2 (pt) dispersão aquosa e usos da mesma
BR112015020089A2 (pt) Formulação aquosa de tratamento de semente, formulação pesticida aquosa, e, método para preparar uma formulação
CA3028338A1 (en) Microencapsulation of bacteriophages and related products
EP3733973A3 (en) Barrier cable coupler
EP3673111A4 (en) FABRIC PRODUCT MADE FROM A LASER ENGRAVED TEXTURING TAPE
MX2020004675A (es) Formulaciones de alcohol de seda.
NZ701697A (en) Stable veterinary anthelmintic formulations
CL2018001017A1 (es) Conservación de vitaminas hidrosolubles.
CO2021009571A2 (es) Polvo de azufre micronizado
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
EP3585447C0 (en) PROCESS FOR PREPARATION OF DOUBLE CROSSLINKED CORE-SHELL POLYMER NANOPARTICLES FOR MULTIMODAL IMAGING AND THERANOSTIC APPLICATIONS
NI201300139A (es) Una composición antiparasitaria y método de tratamiento
EP2923999A3 (en) Die interconnect
AR108149A1 (es) Producto para el cuidado bucal